The summaries are free for public
use. The Chronic Liver Disease
Foundation will continue to add and
archive summaries of articles deemed
relevant to CLDF by the Board of
Trustees and its Advisors.
Abstract Details
Does hepatitis B treatment reduce the incidence of hepatocellular carcinoma?
Sherman M. Hepatology. 2013 Feb 11. doi: 10.1002/hep.26317. [Epub ahead of print]
Source
Department of Medicine, Division of Gastroenterology University of Toronto. morris.sherman@uhn.on.ca.
Abstract
It has been difficult to prove that hepatitis B treatment reduces the incidence of hepatocellular carcinoma. Most previous studies have been retrospective without adequate controls. In this issue of Hepatology Hosaka et al present data on a large cohort, propensity matched for HCC risk with historical controls, demonstrating that HCC incidence is reduced with entecavir therapy (HEPATOLOGY 2013.)